These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22064536)

  • 1. Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in France.
    Garcia M; Raymond J; Garnier M; Cremniter J; Burucoa C
    Antimicrob Agents Chemother; 2012 Jan; 56(1):550-1. PubMed ID: 22064536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB.
    Rimbara E; Noguchi N; Kawai T; Sasatsu M
    Helicobacter; 2012 Feb; 17(1):36-42. PubMed ID: 22221614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
    Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
    Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.
    Wang LH; Cheng H; Hu FL; Li J
    World J Gastroenterol; 2010 May; 16(18):2272-7. PubMed ID: 20458765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.
    Chang WL; Kao CY; Wu CT; Huang AH; Wu JJ; Yang HB; Cheng HC; Sheu BS
    Helicobacter; 2012 Jun; 17(3):210-5. PubMed ID: 22515359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea.
    Lee JW; Kim N; Nam RH; Park JH; Kim JM; Jung HC; Song IS
    Helicobacter; 2011 Aug; 16(4):301-10. PubMed ID: 21762270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates.
    Luzarraga V; Cremniter J; Plouzeau C; Michaud A; Broutin L; Burucoa C; Pichon M
    J Antimicrob Chemother; 2024 Oct; 79(10):2633-2639. PubMed ID: 39126340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance.
    Chung JW; Lee GH; Jeong JY; Lee SM; Jung JH; Choi KD; Song HJ; Jung HY; Kim JH
    J Gastroenterol Hepatol; 2012 Mar; 27(3):493-7. PubMed ID: 21793912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan.
    Hung KH; Sheu BS; Chang WL; Wu HM; Liu CC; Wu JJ
    Helicobacter; 2009 Feb; 14(1):61-5. PubMed ID: 19191898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients.
    Kim JM; Kim JS; Kim N; Jung HC; Song IS
    J Antimicrob Chemother; 2005 Nov; 56(5):965-7. PubMed ID: 16159928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point Mutations at
    López-Gasca M; Peña J; García-Amado MA; Michelangeli F; Contreras M
    Am J Trop Med Hyg; 2018 Apr; 98(4):1051-1055. PubMed ID: 29405113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium.
    Bogaerts P; Berhin C; Nizet H; Glupczynski Y
    Helicobacter; 2006 Oct; 11(5):441-5. PubMed ID: 16961806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria.
    Bachir M; Allem R; Benejat L; Tifrit A; Medjekane M; Drici AE; Megraud F; Douidi KT
    J Antimicrob Chemother; 2018 Aug; 73(8):2034-2038. PubMed ID: 29762682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of Levofloxacin Resistance in Helicobacter pylori Isolates in Bogotá-Colombia (2009-2014).
    Trespalacios-Rangél AA; Otero W; Arévalo-Galvis A; Poutou-Piñales RA; Rimbara E; Graham DY
    PLoS One; 2016; 11(7):e0160007. PubMed ID: 27454429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy.
    Mori H; Suzuki H; Matsuzaki J; Masaoka T; Kanai T
    Digestion; 2020; 101(5):644-650. PubMed ID: 31387107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea.
    Lee JW; Kim N; Nam RH; Park JH; Choi YJ; Kim JM; Kim JS; Jung HC
    Scand J Gastroenterol; 2014 Sep; 49(9):1058-67. PubMed ID: 24957849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies.
    Matsuzaki J; Suzuki H; Nishizawa T; Hirata K; Tsugawa H; Saito Y; Okada S; Fukuhara S; Hibi T
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1643-5. PubMed ID: 22203601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori.
    Tankovic J; Lascols C; Sculo Q; Petit JC; Soussy CJ
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3942-4. PubMed ID: 14638505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into resistance of Helicobacter pylori against third- and fourth-generation fluoroquinolones: A molecular docking study of prevalent GyrA mutations.
    Salehi N; Attaran B; Eskini N; Esmaeili M; Sharifirad A; Sadeghi M; Mohammadi M
    Helicobacter; 2019 Oct; 24(5):e12628. PubMed ID: 31282059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan.
    Miyachi H; Miki I; Aoyama N; Shirasaka D; Matsumoto Y; Toyoda M; Mitani T; Morita Y; Tamura T; Kinoshita S; Okano Y; Kumagai S; Kasuga M
    Helicobacter; 2006 Aug; 11(4):243-9. PubMed ID: 16882327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.